SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-006454
Filing Date
2021-02-03
Accepted
2021-02-03 16:40:43
Documents
1
Period of Report
2021-01-28
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea134566-8k_180lifescien.htm 8-K 31429
  Complete submission text file 0001213900-21-006454.txt   32706
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 21586725
SIC: 2834 Pharmaceutical Preparations